Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nicotinamide Riboside for Mitochondrial Myopathy
NCT05590468Phase 2Active, not recruiting
- Start
- May 2023
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of nicotinamide riboside in mitochondrial myopathy (MM). Started May 2023; status: active, not recruiting.
02
Drugs
nicotinamide riboside
03
Conditions
mitochondrial myopathy (MM)
Beyond the preview
Go deeper on NCT05590468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05590468.